A Brazilian study found that people with mild cognitive impairment who took lithium daily had decreased levels of phosphorylated tau (p-tau), a marker for Alzheimer's disease, and performed better on cognitive tests compared to those treated with placebo

factualpending

Speaker

Anna

Evidence Quote

“people with mild cognitive impairment who took lithium daily had decreased levels of a marker for Alzheimer's disease known as p and they also performed better on cognitive tests compared to those treated with Placebo”

Source

Lithium | Neurologist Reviews Evidence and Top Brands— Neurogal MD
Created: 8/10/2026, 9:28:36 PM

Your notes

Loading notes...